The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
Dr Robert Gabbay on the Intersection of COVID-19 and Diabetes
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, shares his thoughts on long COVID-19 among those with type 2 diabetes and the rise of new-onset cases of type 1 diabetes throughout the pandemic.
SURPASS-5 Data: Tirzepatide Plus Insulin Glargine Improve Glycemic Control in T2D
Data from SURPASS-5 show Eli Lilly's glucagon-like peptide-1 receptor agonist tirzepatide helped improve glycemic control when taken with insulin glargine.
Dr Robert Gabbay Discusses Management of Pediatric Type 1, 2 Diabetes
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses some of the challenges of treating pediatric patients with type 1 or type 2 diabetes.
Insulet's Omnipod 5 Cleared by FDA
The FDA has cleared the first tubeless automated insulin delivery system with a smartphone app control.
Increases in Pediatric T1D Incidence Seen During COVID-19
Findings from 2 studies conducted among German and US children highlight the growing incidence of type 1 diabetes (T1D) among children throughout the COVID-19 pandemic.
Contributor: Empowering Endocrinologists With Technology for the Diagnosis, Management, and Treatment of NAFLD
In this column, an endocrinologist discusses the growing problem of liver disease and new options at their disposal, including vibration-controlled transient elastography.
SDOH-Induced Changes to Gut Microbiome Could Contribute to Racial Disparities in T2D
Findings of a pilot study suggest that gut microbiome differences resulting from environmental factors could affect racial disparities in type 2 diabetes.
Diabetes Medication Costs, Utilization Differed by Medicaid or Marketplace Enrollment
New data show that Medicaid enrollees with diabetes in Colorado have greater access to new medications and incur less associated costs compared with patients with Marketplace plans.
Decrease in Diabetes All-Cause Mortality Seen in High-Income Countries
New data revealed that rates of all-cause mortality among those with diabetes decreased between 1995 and 2016 in high-income countries.
Researchers Propose Model to Replicate Patient Experience in Artificial Pancreas System
A methodology to monitor patient-in-the-loop modes and faults was examined using a hybrid automata model that was able to replicate patient’s real-life operation modes.
Review: Commercially Developed, Open-Source AID Systems Deemed Safe and Effective
Gleaning data from real-world studies, investigators determined that commercially developed and open-source automated insulin dosing systems are safe and effective.
Study Supports Call for Geographically Tailored Diabetes Care Interventions
Patients with diabetes living in rural or deprived regions in the United States are less likely to achieve optimal care for their condition, according to a new cross-sectional study.
Top 5 Most-Read Type 1 Diabetes Articles of 2021
The most popular type 1 diabetes articles published in 2021 included new research on screening and updated coverage policy.
Analysis Highlights Disparities in GLP-1 RA Access
An analysis uncovered racial, ethnic, and socioeconomic inequities regarding access to glucagon-like peptide-1 receptor agonists among US patients with diabetes.
Family History of T2D May Increase MACE Risk in Those With T1D
A study carried out in Taiwan found that a family history of type 2 diabetes (T2D) may increase the risks of diabetes-related complications in those with type 1 diabetes (T1D).
Top 5 Most-Read Diabetes Articles of 2021
New research on semaglutide and empagliflozin appear on this year’s list of most-read diabetes articles.
Study: Racial-Ethnic Disparities in T1D Technology Use Worsened From 2017 to 2019
Between coverage years 2017 and 2019, racial-ethnic disparities in diabetes technology use worsened among Medicare beneficiaries with type 1 diabetes.
Experts Examine the Association Between Retinal Damage, DKD Presence in Patients With T2D
Results of a cross-sectional study fond diabetic kidney disease (DKD) was associated with retinal changes in patients with type 2 diabetes (T2D).
Review: Smartphone Apps May Improve Outcomes in Gestational Diabetes
Results of a systemic review found evidence potentially supporting the use of smart phone applications among mothers with gestational diabetes.
Does Gender-Affirming Hormone Therapy Affect T2D Risk?
Results of a cohort study showed that transfeminine individuals may be at a higher risk for type 2 diabetes (T2D) compared with cisgender females, but revealed little evidence that gender-affirming hormone therapy impacts diabetes risk.
Variability in Statin Use Seen Among Finnish T2D Population
Data showed differences in statin use to prevent cardiovascular disease among Finnish patients with type 2 diabetes.
Contributor: CMS Has Decided to Put Its Muscle Behind Glycemic Management—Why Now?
CMS' introduction of 3 new electronic clinical quality measures, 2 of which are focused on inpatient glycemic management, signal a strong commitment to shine a light on this often-overlooked area, according to the chief medical officer at Glytec.
Dr Robert Gabbay Outlines How the Health Equity Now Initiative Addresses Diabetes Care Disparities
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, explains the Health Equity Now initiative and how it shines a light on health disparities.
Dr Robert Gabbay on COVID-19 Vaccinations in the Diabetes Community
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses COVID-19 vaccinations among people with diabetes as they have been disproportionally affected by the pandemic.
Challenges With Implementing the Diabetes Prevention Program for Medicare Beneficiaries in an Integrated Health System
This study presents challenges of implementing the CDC-approved Diabetes Prevention Program for Medicare beneficiaries at a large, integrated health care delivery system.
Analysis Details Factors Associated With T2D Development Among Women With PCOS
Results of a cross-sectional study detail characteristics among women with polycystic ovary syndrome (PCOS) who develop type 2 diabetes.
Study Evaluates Impact of Food Environments on T2D Risk
Results of a longitudinal study indicate community food accessibility factors may impact type 2 diabetes risk among veterans.
Research Highlights Racial/Ethnic Diabetes Disparities Based on Age of Diagnosis
New research underscores racial/ethnic diabetes disparities in the United States.
Dr Robert Gabbay Discusses SGLT2 Inhibitor Uptake Among Cardiologists, Nephrologists
As time goes on, we're finding out more and more benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors, said Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association.
Intensifying Diabetes Medication Regimen at Hospital Discharge May Not Benefit Older Patients
Results of a retrospective study found no benefits among older patients whose diabetes medication was intensified following short hospital admissions.
2 Clarke Drive Cranbury, NJ 08512